Lakewood-Amedex Biotherapeutics, Inc.

LABT·NasdaqCM·Healthcare
Compare
0.1914−0.0036 (−1.85%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market0.1800−0.0114 (−5.96%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.1950
Open0.1892
Day range0.17310.1999
52-week range0.170098.2000
Off day high−4.25%
Off 52-week high−99.81%
Volume790.87K
Avg. volume (3M)2.41M
Market cap453.56K
EPS (TTM)-8.83
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding2.37M
Short interest7.39% of float
Earnings date—
Analyst target7.5000
Profit margin0.00%

Against its peers

Compare in full ›
LABT BDRX ACXP ONCO ELAB PMCB
Market cap 453.56K 1.41M 5.64M 3.88M 1.55M 4.09M
P/E (TTM) — 0.0 — 0.0 — —
Forward P/E — — -0.6 -0.8 — -1.0
Price/book 0.1 0.0 0.6 0.2 0.1 0.1
Dividend yield — — — — — —
1-year change −99.78% −98.73% −80.19% −99.63% −99.85% −61.58%
Today −1.85% −4.61% +0.98% +15.69% −1.03% +12.03%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All LABT news ›
MarketScreener··2 outletsPositive

Lakewood-Amedex Biotherapeutics Inc Announces Positive Data For The Advancement of Lead Candidate Nu-3 In Infected Diabetic Foot Ulcers

Lakewood-Amedex Biotherapeutics Inc. announced positive data for its lead compound, Nu-3, as it advances towards a Phase 2 trial. Nu-3 is being developed as a topically delivered treatment for mildly... announced positive data for its lead…

More from 1 other outlet
@PRNewswire·Positive

News from Lakewood-Amedex Biotherapeutics Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

news News from Lakewood-Amedex Biotherapeutics Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.…

MarketScreener··2 outletsPositive

Lakewood-Amedex Biotherapeutics Inc. Presents Data Highlighting Nu-3's Broad-Spectrum Antimicrobial Activity And Low Potential For Resistance At IDWeek 2026

Lakewood-Amedex Biotherapeutics Inc. announced the presentation of research highlighting the antimicrobial profile of Nu-3, the Company's lead clinical candidate, at IDWeek 2026. The poster, titled, ... announced the presentation of…

More from 1 other outlet
MarketScreener··2 outletsPositive

Lakewood-Amedex Biotherapeutics Inc. Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds

Lakewood-Amedex Biotherapeutics Inc. announced positive preclinical data in urinary tract infection and pulmonary infection indications in animal models treated with Bisphosphocin® compounds. In an... announced positive preclinical data in…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

11mentions in 30 days
11with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance